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Abstract 
 
The expression of Interferon (IFN)-β is highly induced in immune and non-immune 
cells in response to virus infection. This upregulation is mediated at both transcriptional 
and posttranscriptional levels. Whereas the signaling pathways triggered by innate virus 
receptors leading to transcription factor activation have been extensively studied, the 
mechanisms by which IFN-β mRNA stability is posttranscriptionally controlled are not 
fully understood. In this issue of the European Journal of Immunology, Herdy et al. [Eur. 
J. Immunol. 2015 45:XXXX-XXXX] show that a human RNA-binding protein, 
Embryonic Lethal, Abnormal Vision, Drosophila-Like 1 (ELAVL1)/Hu antigen R (HuR), 
strongly associates with IFN-β mRNA via AU-rich sequences present in its 3’ 
untranslated region in various human cell lines. The authors show that ELAVL1/HuR is 
required for the stabilization of IFN-β mRNA, and suppression of ELAVL1/HuR by its 
inhibitor MS-444 leads to impaired expression of IFN-β in response to viral dsRNA 
treatment. Thus, this study uncovers a novel mechanism of posttranscriptional IFN-β 
mRNA regulation in response to virus infection, through IFN-β stabilization by 
ELAVL1/HuR. Future studies are expected to identify further regulatory mechanisms of 
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See accompanying article by Herdy et al.
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Main text 
Type I Interferons (IFNs), comprised of multiple IFN-α isoforms and an IFN-β, are 
critical for innate and adaptive antiviral host defense as well as for the pathogenesis of 
autoimmunity [1, 2]. Secreted type I IFNs subsequently stimulate the type I IFN 
receptor (IFNAR) to transactivate a set of IFN-stimulated genes (ISGs) in autocrine and 
paracrine manners. The expression of type I IFN mRNAs is rapidly induced by the 
recognition of virus infection via a set of pattern recognition receptors (PRRs) such as 
Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) 
and viral DNA sensors [3]. TLRs are transmembrane proteins recognizing microbial 
components on the cell surface or in the endosomes. Among the TLRs expressed on the 
endosome, TLR3, TLR7 and TLR9 sense viral double-stranded (ds) RNA, 
single-stranded (ss) RNA and DNA with a CpG motif respectively. Other PRRs, such as 
the cytoplasmic RLRs, RIG-I and Melanoma differentiation-associated gene 5 (MDA5), 
recognize 5’-triphosphate end dsRNA and long dsRNA respectively [4]. Extensive 
studies have revealed the PRR signaling pathways leading to transcription of type I 
IFNs via transcription factors including IFN-regulatory factor (IRF) 3 and IRF7 [1]. 
PRR signaling also activates another transcription factor, NF-κB, which contributes to 
the transactivation of proinflammatory cytokines as well as IFN-β. However, 
posttranscriptional regulation is also important for the regulation of mRNAs for type I 
IFNs and proinflammatory cytokines [5, 6]. 
 
It is well known that mRNAs encoding proinflammatory cytokines and type I 
IFNs have short half-lives, which is understood to be important for preventing 
unnecessarily sustained inflammation[7]. The regulation of cytokine mRNAs such as 
TNF and IL-6 has been shown to be mediated by cis-acting elements present in the 3′ 
untranslated regions (UTRs) and the coding region, including AU-rich elements (AREs) 
and stem-loop structures [5-7]. AREs are known to be recognized by various 
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RNA-binding proteins (BPs) called ARE-BPs. Among these, tristetraprolin (TTP), 
ARE/poly-(U) binding degradation factor 1 (AUF1), and KH domain-splicing 
regulatory protein (KSRP) are reported to be involved in the destabilization of mRNAs 
harboring AREs (Figure 1A). For instance, TTP decreases TNF mRNA stability by 
binding to AREs present in its 3′ UTRs, leading to deadenylation by recruitment of a 
CCR4-NOT deadenylase complex (Figure 1A) [8, 9]. In contrast, the RNA-binding 
protein Embryonic Lethal, Abnormal Vision, Drosophila-Like 1 (ELAVL1)/Hu antigen 
R (HuR) has been shown to be involved in increasing the stability of these mRNAs [5, 
10, 11]. In addition, stem-loop structures present in the 3’ UTR of TNF and IL-6 
mRNAs also act as cis-elements for their destabilization. For instance, stem-loop 
structures present in a set of mRNAs, including those encoding ICOS, OX40 and TNF, 
have been shown to promote mRNA instability  via Roquin-1 and Roquin-2, which 
interact with a ROQ domain within the stem-loop [12, 13]. Furthermore, an RNase 
called Regnase-1 (also known as Zc3h12a) has been shown to degrade IL-6 mRNA via 
a stem-loop sequence present in its 3’ UTR [14, 15]. The mechanisms controlling the 
stability of IFN-β mRNA, however, are not yet fully understood. 
 
In this issue of the European Journal of Immunology, Herdy et al. first 
demonstrate that an ARE present in the 3’ UTR of IFN-β mRNA causes the mRNA to 
be destabilized in HeLaS3 cells [16]. In contrast, an IFN-β mRNA destabilizing element 
present in the coding region instability determinant (CRID) showed only a modest effect 
in destabilizing IFN-β mRNA in this cell type (Figure 1B). Whereas IFN-β mRNA 
exhibits a relatively short half-life, the mRNA was stabilized in response to stimulation 
with Polyinosinic–polycytidylic acid (Poly I:C), a viral dsRNA analog recognized by 
TLR3 and MDA5. These results suggest that TLR and/or RLR signaling may control 
the stability of IFN-β mRNA via the 3’ UTR.  
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To identify proteins interacting with the ARE, the authors combined affinity 
purification of ARE20 RNA, which comprises the first 20 nucleotides of the IFN-β ARE, 
with mass spectrometry to isolate and identify proteins interacting in this region. Among 
93 proteins obtained by mass spectrometry, ELAVL1/HuR was identified as the sole 
ARE-binding protein associating with the IFN-β ARE (Figure 1B) [16]. In contrast, 
ARE-BPs known to destabilize mRNAs, such as TTP, AUF1 and KSRP, were not 
present in the proteins co-precipitated with the IFN-β ARE. A previous study using 
PAR-CLIP analysis of HuR-binding mRNA sites had revealed that HuR- and 
microRNA-binding sites tend to reside in proximity to each other in HEK293 cells, 
implying that dimerized HuR stabilizes mRNAs by preventing microRNA-mediated 
degradation [17]. If TTP, AUF1 and KSRP are not responsible for driving IFN-β  
mRNA instability, could microRNAs, then, be responsible for promoting IFN-β  mRNA 
decay?  Further studies may identify microRNA(s) responsible for the degradation of 
IFN-β mRNAs, which bind close to the ARE.  
 
Although the half-life of IFN-β mRNA was short in unstimulated cells, it was 
dramatically stabilized following 8 hours of poly I:C stimulation [16]. Furthermore, this 
stabilization ceased after 16 hours of stimulation, indicating that the stability of IFN-β 
mRNA is tightly and transiently controlled by TLR and RLR signaling. TTP has been 
shown to be phosphorylated by the p38 mitogen-activated protein kinase 
(MAPK)-activated kinase MK2 in the course of MAP kinase signaling, which occurs 
downstream of stimulation by various cytokines and PRRs. TTP phosphorylation 
induces formation of a complex between TTP and 14-3-3, which dissociates TTP from 
stress granules and inhibits recruitment of the CCR4-NOT complex [18, 19]. Whereas 
TTP was not identified as an IFN-β ARE-BP in this study, it is possible that a different 
ARE-BP acting on IFN-β mRNA is modified in the course of poly I:C stimulation. 
Although the binding of ELAVL1/HuR to the IFN-β ARE was not altered in the course 
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of stimulation [16], it is interesting to speculate that the activity of ELAVL1/HuR to 
stabilize IFN-β mRNA is dynamically controlled by TLR and RLR signaling. 
Alternatively, poly I:C-triggered signaling pathways may alter the expression of a set of 
microRNAs controlling the stability of IFN-β mRNA. Further studies are however 
required to understand the molecular mechanisms controlling IFN-β mRNA stability 
upon virus infection. 
 
When HuR expression was depleted with siRNA, the expression of IFN-β 
mRNA in response to poly I:C stimulation was severely impaired in HeLaS3 cells [16]. 
Furthermore, the antiviral activity of poly I:C-stimulated HeLaS3 cell supernatants was 
diminished in response to knockdown of ELAVL1/HuR. Therefore, HuR is critical for 
the expression of IFN-β mRNA and antiviral responses to TLR3 and MDA5 activation. 
The activity and importance of HuR in the stability of IFN-β mRNA was further 
confirmed by inhibition of HuR with a chemical compound, MS-444. Consistent with 
HuR knockdown, MS-444 treatment suppressed the expression of IFN-β in response to 
poly I:C stimulation in HeLaS3 cells. MS-444 also showed inhibitory effects in 
controlling IFN-β expression in fibroblast-like synoviocytes. Although type I IFNs are 
critical for protection against virus infections, their pathogenic roles in autoimmunity 
and bacterial infection have also been documented [2]. Therefore, suppression of IFN-β 
mRNA expression by inhibitors of ELAVL1/HuR might be useful for the treatment of 
such diseases. Given that the concentration of MS-444 required for the suppression of 
IFN-β mRNA is relatively high, further evaluation is required to identify more efficient 
small molecules for the suppression of HuR dimerization. 
 
Herdy et al. focused on non-immune cells such as HeLaS3 and synovial 
fibroblast cells for assessing the requirement of ELAVL1/HuR for IFN-β mRNA 
expression [16]. However, it is well known that myeloid immune cells, such as 
  7 
macrophages and conventional or plasmacytoid dendritic cells, are the major producers 
of type I IFNs in response to virus infection [20]. Therefore, it will be interesting to 
investigate if IFN-β mRNA stability is controlled by ELAVL1/HuR in a similar manner 
in these cells. 
 
In summary, this study provides new insights into the molecular mechanisms 
controlling type I IFN production in response to viral infection. Future studiesmay 
further characterize the mechanisms and importance of posttranscriptional regulation of 
IFN-β in antiviral immune responses. 
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Figure 1. HuR-mediated stabilization of IFN-β mRNA via the 3’ UTR. 
(A) The regulation of cytokine mRNAs such as TNF has been shown to be mediated by 
cis-acting elements present in the 3′ untranslated regions (UTRs), including AU-rich 
elements (AREs), and within the coding region, known as CRID. AREs are known to be 
recognized by various RNA-binding proteins (ARE-BPs). Among these, tristetraprolin 
(TTP), ARE/poly-(U) binding degradation factor 1 (AUF1), and KH domain-splicing 
regulatory protein (KSRP) are reported to be involved in the destabilization of mRNAs 
harboring AREs. For instance, TTP decreases TNF mRNA stability by binding to AREs 
present in its 3′ UTRs, leading to deadenylation by recruitment of a CCR4-NOT 
deadenylase complex . 
(B) IFN-β mRNA harbors two destabilization sequences, CRID and ARE. Although the 
known ARE-BPs driving mRNA instability were not identified by Herdy et al. [16], 
HuR may act to ARE-BP acting on IFN-β mRNA is modified in the course of poly I:C 
stimulation 
 
